| 产品详情 |
| Edit |   |
|---|
| Product Name | Lactate Dehydrogenase A Inhibitor, FX11 |
|---|
| Description | Purity ~96% (HPLC). A cell permeable, gossypol analog that acts as a selective, reversible, and NADH competitive inhibitor of lactate dehhydrogenase A (LDHA; Ki = 8uM for human liver LDHA). Does not affect the activities of LDHB and glyceraldehyde-3-phosphate dehydrogenase even at higher concentrations. Shown to increase oxygen consumption, reactive oxygen species production, and cell death in P493 human lymphoma B cells. Also shown to reduce mitochondrial transmembrane potential and ATP levels and increase AMP kinase activity. Exhibits synergistic toxicity in P493 cells when combined with FK866. Blocks the progression of human lymphoma and pancreatic cancer xenografts and when used in combination with FK866 it induces lymphoma regression. Solubility: DMSO Water by CHN (mol): ≤0.1mol Carbon: 73.0-76.0% Hydrogen: 5.5-7.5% |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Lactate Dehydrogenase A Inhibitor, FX11 (LDHA Inhibitor I, LDH-A Inhibitor I, LDH-M Inhibitor I, LDHM Inhibitor I) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217507 |
|---|
| Price | |
|---|
| Order / More Info | Lactate Dehydrogenase A Inhibitor, FX11 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|